Durect Pharma: Corporate Presentation (Durect) - Sep 3, 2013 - Anticipated patent coverage in US for pain through 2031; Anticipated patent coverage in EU for pain through 2023; Anticipated eligible patent term extension for pain through 2033/2034
Anticipated patent expiry • Pain
|